Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

CERS

CERUS CORP

Surgical & Medical Instruments & Apparatus · SIC 3841CIK 1020214Held by 2 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$234.0M
Net Income FY2025
$(16.0M)
EPS (Basic, as reported)
$-0.08
Net Margin FY2025
-6.7%
ROE FY2025
-24.3%
Total Equity
$64.0M
Shares Out
202M
Business description

CERUS CORP — Surgical & Medical Instruments & Apparatus. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2009–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 39 → 234 +22% CAGR
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue39517694114160188187201234
Cost of revenue(20)(23)(32)(33)(41)—————
Gross profit17—————————
Selling, general & administrative(49)(52)(57)(66)(67)(81)(83)(76)(76)(81)
Total operating expenses(80)(86)(99)(127)(131)(145)(147)(147)(135)(149)
Operating income(61)(58)(55)(66)(58)(49)(34)(30)(14)(9)
Interest expense(2)(3)(4)(6)(4)(5)(6)(8)(9)(8)
Other income (expense), net(1)1(2)(5)(1)(5)(8)(7)(7)(7)
Pre-tax income(63)(57)(57)(71)(60)(54)(42)(37)(21)(15)
Income tax expense0(4)00000000
Net income(63)(61)(58)(71)(60)(54)(43)(37)(21)(16)
EPS — basic($0.62)($0.56)($0.44)—($0.37)($0.32)($0.24)($0.21)($0.11)($0.08)
EPS — diluted($0.62)($0.56)($0.44)—($0.37)($0.32)($0.24)($0.21)($0.11)($0.08)
Shares outstanding — basic (M)102108132140164171177180185191
Shares outstanding — diluted (M)102108132140164171177180185191

Showing the latest 10 of 17 fiscal years.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.